ZP123 Increases Gap Junctional Conductance and Prevents Reentrant Ventricular Tachycardia During Myocardial Ischemia in Open Chest Dogs
- 12 May 2003
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 14 (5) , 510-520
- https://doi.org/10.1046/j.1540-8167.2003.02329.x
Abstract
Introduction: The aim of this study was to determine if the stable antiarrhythmic peptide (AAP) analogue ZP123 increases gap junctional intercellular conductance and prevents reentrant ...Keywords
This publication has 26 references indexed in Scilit:
- Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activationThe FASEB Journal, 2002
- Electrophysiologic Remodeling:.Journal of Cardiovascular Electrophysiology, 1999
- Slow ventricular conduction in mice heterozygous for a connexin43 null mutation.Journal of Clinical Investigation, 1997
- Therapeutic Potential of Antiarrhythmic PeptidesDrugs, 1995
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Antiarrhythmic peptide has no direct cardiac actionsCellular and Molecular Life Sciences, 1989
- Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 casesAmerican Heart Journal, 1989
- Effect of N-3-(4-hydroxyphenyl)propionyl Pro-Pro-Gly-Ala-Gly on calcium-induced arrhythmias.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- A new antiarrhythmic peptide, N-3-(4-hydroxyphenyl)propionyl Pro-Hyp-Gly-Ala-Gly.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Studies on heart. XXI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria.Journal of Pharmacobio-Dynamics, 1982